LEPTIN TREATMENT IN GENERALIZED LIPODYSTROPHY

瘦素治疗全身性脂肪营养不良

• 批准号: 7606313
• 负责人: Abhimanyu Garg
• 金额: $ 0.89万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606313
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Familial generalized lipodystrophy; Funding; Glucose; Grant; Institution; Leptin; Lipids; Patients; Plasma; Research; Research Personnel; Resources; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this study are as follows: 1) To determine if leptin can be safely administered to a group of patients with generalized lipodystrophy. 2) To determine if leptin treatment will be effective in lowering plasma glucose and lipid abnormalities in patients with generalized lipodystrophy.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的目标如下： 1）确定瘦素是否可以安全地给予一组广义脂肪营养不良的患者。 2）确定瘦素治疗是否有效降低普通脂肪营养不良患者的血浆葡萄糖和脂质异常。